NASDAQ / LIVE COMPANY INTELLIGENCE

Yarrow Bioscience, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERYARW
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / YARW COVERAGE

What’s moving Yarrow Bioscience, Inc. now

Current reporting with the operating signal separated from the noise.

01
Faits marquants Yarrow Bioscience, Inc.

Faits marquants Yarrow Bioscience, Inc.

The development tests whether Yarrow Bioscience, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
02
Insiders Yarrow Bioscience, Inc.

Insiders Yarrow Bioscience, Inc.

The story matters when it changes Yarrow Bioscience, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest YARW filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-27 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-30 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-07-28 · Period 2026-07-24SEC ↗8-KMaterial company eventFiled 2026-07-21 · Period 2026-07-21SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-11-12 · Period 2025-12-12SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-08-04SEC ↗
EARNINGS / QUARTERLY TRACKER

Yarrow Bioscience, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.